MATINAS BIOPHARMA HOLDINGS, INC. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales AgreementMatinas Biopharma • April 28th, 2017 • Matinas BioPharma Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 28th, 2017 Company Industry JurisdictionMatinas BioPharma Holdings, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: